By Daniella Parra ProSomnus, Inc. (NASDAQ: OSA) is set to feature its precision sleep apnea devices in upcoming medical conferences, showcasing new data on the efficacy, safety and effectiveness of ProSomnus devices, it said. One study compared precision oral appliance...

By Tech Edge Editorial Qualtrics’ “Complaints and Grievances” solution for the healthcare industry will help improve the patient experience, which can be deeply personal, frightening and fraught with layers of process and paperwork, according to The Futurum Group. The solution...

By Karen E. Roman The Federal Communications Commission (FCC) is assessing the potential threat of Chinese cellular devices to track and infiltrate U.S. intelligence through connected devices on the Internet of Things (IoT), according to a recent article from The...

By Daniella Parra Sparrow Pharmaceuticals expanded its Phase 2 clinical trial for SPI-62 in combination with prednisolone to treat polymyalgia rheumatica (PMR), the company said. The trial is exploring the potential benefits of SPI-62 in reducing the side effects of...

By Tech Edge Editorial MongoDB (Nasdaq: MDB), a data platform player company, reported total revenue of $423.8 million in its second quarter results, a 40% increase year-over-year. The company saw a gross profit of $318.5 million, 75% gross margin compared...

By Daniella Parra Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company specializing in advanced radiotherapeutics for brain cancer, said it will present data from its ReSPECT-LM clinical trial at the CPRIT Innovations in Cancer Prevention and Research Conference VI....

By Daniella Parra Plus Therapeutics, Inc. (Nasdaq: PSTV) has expanded its partnership with Biocept with an exclusive option to license a diagnostic platform for central nervous system cancer patients undergoing radiotherapy, the company said. CNSide is a proprietary assay that...

By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) is partnering with Lineage Cell Therapeutics, Inc. to develop stem cell lines for central nervous system diseases, the company said. Eterna’s mRNA gene-editing approach and Lineage’s expertise in gene editing aim to...

  By Karen E. Roman Octave Bioscience, Inc., a company offering treatment for multiple sclerosis and other neurodegenerative diseases, said it will conduct a real-world study with its sponsor Biogen (Nasdaq: BIIB) evaluating 150 patients using the Octave Precision Care Solution....

By Exec Edge Editorial Morrow Sodali, a global stakeholder engagement and ESG consulting firm, appointed Barri Rafferty as CEO, Americas. Rafferty, known for her leadership at Wells Fargo and Ketchum, brings extensive experience in modernizing organizations and promoting diversity, the...